首页> 美国卫生研究院文献>Asia Oceania Journal of Nuclear Medicine and Biology >Predictive Ability of 18F-fluorodeoxyglucose Positron Emission Tomography/computed Tomography for Pathological Complete Response and Prognosis after Neoadjuvant Chemotherapy in Triple-negative Breast Cancer Patients
【2h】

Predictive Ability of 18F-fluorodeoxyglucose Positron Emission Tomography/computed Tomography for Pathological Complete Response and Prognosis after Neoadjuvant Chemotherapy in Triple-negative Breast Cancer Patients

机译:18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描对三阴性乳腺癌患者新辅助化疗后病理学完全缓解和预后的预测能力。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objective(s):The mortality of patients with locally advanced triple-negative breast cancer (TNBC) is high, and pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) is associated with improved prognosis. This retrospective study was designed and powered to investigate the ability of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG-PET/CT) to predict pathological response to NAC and prognosis after NAC.
机译:目的:局部晚期三阴性乳腺癌(TNBC)患者的死亡率很高,对新辅助化疗(NAC)的病理完全缓解(pCR)与预后改善相关。这项回顾性研究旨在研究 18 F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描( 18 F-FDG-PET / CT)预测病理反应的能力NAC和NAC后的预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号